BioSpace News Archive

Tevard Biosciences , Inc., the pioneer of tRNA-based therapies for severe genetic diseases, today announced a four-year global research collaboration with Vertex Pharmaceuticals Incorporated aimed at creating new tRNA-based therapies for patients with Duchenne muscular dystrophy (DMD).

Windtree Therapeutics, Inc. announced that its preclinical stage drug candidates called SERCA2a Activators were featured in a publication in The Journal of Pharmacology and Experimental Therapeutics entitled “Istaroxime Metabolite PST3093 Selectively Stimulates SERCA2a and Reverses Disease-Induced Changes in Cardiac Function.”

Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that Sean Browne, Chief Executive Officer, will present at the Canaccord Musculoskeletal Conference, to be held on Tuesday, March 7, 2023 at 3:30 p.m. Pacific Time in Las Vegas.

Bolt Biotherapeutics announced that management will present a company overview at the Cowen 43rd Annual Healthcare Conference on Tuesday, March 7, 2023, at 2:50 p.m. EST in Boston, Mass.

Immuneering Corporation today announced that management will participate in two March investor conferences to share commentary around the company’s pipeline, platform, and business strategy.

Rockwell Medical, Inc. announced that it has been certified as a Great Place to Work® in 2023, the Company’s inaugural year participating in the accreditation.

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today issued its financial results for the fourth quarter and the full year ended December 31, 2022.

Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, announced today that Scott Hutton, Chief Executive Officer of Biodesix, will participate in a fireside chat and host in-person 1x1 investor meetings at Cowen’s 43rd Annual Healthcare Conference being held from March 6-8, 2023.

Owens & Minor, Inc. reported financial results for the fourth quarter and the year ended December 31, 2022, as summarized in the table below.

Clover Health Investments, Corp. today reported financial results for the fourth quarter and full year 2022.